欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0237/001
药品名称Gadovist 0,5 mmol/ml
活性成分
    • gadobutrol 302.0 mg
剂型Solution for injection
上市许可持有人Schering Deutschland GmbH Max-Dohrn-Str. 10 D-10589 Berlin
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
      Gadovist
    • United Kingdom (Northern Ireland) (XI)
      Gadovist
    • Ireland (IE)
    • Austria (AT)
      Gadovist 0,5 mmol/ml-Injektionsl”sung
    • France (FR)
      GADOVIST
    • Spain (ES)
      GADOVIST 0,5 mmol/ml solución inyectable
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
      Gadovist
    • Norway (NO)
    • Finland (FI)
许可日期2000/06/15
最近更新日期2012/08/09
药物ATC编码
    • V VARIOUS
    • V08 CONTRAST MEDIA
    • V08C MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
    • V08CA Paramagnetic contrast media
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase